Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:379
doi: 10.1161/01.ATV.0000060480.24963.EE
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabbiani, G.
Right arrow Articles by Hansson, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabbiani, G.
Right arrow Articles by Hansson, G. K.
Related Collections
Right arrow Smooth Muscle Cells
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:379.)
© 2003 American Heart Association, Inc.


ATVB In Focus

ATVB In Focus

Smooth Muscle Cells

Giulio Gabbiani; Göran K. Hansson

From the Department of Pathology (G.G.), Centre Médical Universitaire, Geneva, and Karolinska Institutet/Center for Molecular Medicine (G.K.H.), Stockholm, Sweden.

Correspondence to Dr Giulio Gabbiani, Department of Pathology, CMU, 1, rue Michel-Servet, 1211 Geneva 4, Switzerland. E-mail Giulio.Gabbiani@medecine.unige.ch


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

One of the implications of the original observation by Benditt and Benditt1 that human atheromatous plaques have the features of a monoclonal proliferation is that arterial smooth muscle cells (SMCs) are heterogeneous and that possibly a distinct SMC subpopulation exhibits the propensity to migrate into the intima and to participate in atheroma formation. This has inspired an important number of investigations with the aim of isolating and defining distinct SMC phenotypes or of identifying different SMC precursors during development and/or pathological situations.

See page 380

Evidence has been produced that SMCs in culture may display distinct phenotypic features, eg, spindle-shaped or epithelioid morphology. These populations have been shown to derive from tissues with different biological characteristics, such as normal media and intimal thickening after endothelial injury2 or normal media of newborn versus old rats.3 It has also been shown that SMC populations and clones with these distinct morphologies can be isolated from the same tissue, eg, normal media.4 Most of this work has been performed with the rat as experimental animal, but more recently, these observations have been extended to other species, such as cow, dog, and pig, and albeit sporadically, human.5,6

It has also been attempted to identify markers of the different phenotypes, with some success in the rat model,7 but unfortunately, results in rodents are not necessarily applicable to other species and to humans in particular. A significant impulse to this conceptual approach has been given by the demonstration that circulating or bone marrow–derived cells can contribute to . . . [Full Text of this Article]